Annex II to the call for proposals - Vendor financial identification form
Annex II to the call for proposals - Vendor financial identification form
Annex II to the call for proposals - Vendor financial identification form
Committee for Medicinal Products for Human Use (CHMP): 19-22 February 2024, European Medicines Agency, Amsterdam, the Netherlands, from 19 February 2024 to 22 February 2024
SPOR Status Update, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 July 2024, 10:00 (CEST) to 10 July 2024, 12:30 (CEST)
Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI)
Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI) - ATMP
Timetable: Post-authorisation measure (PAM) Paediatric art. 46 submission - ATMP
Timetable: Post-authorisation measure (PAM) assessed by CHMP
Timetable: Post-authorisation measures (PAMs) assessed by PRAC - ATMP
Timetable: Post-authorisation measure (PAM) assessed by PRAC
Timetable: Initial (full) marketing authorisation application accelerated assessment timetables